GKAT - AI Analysis

Compare

Top Page

Scharf Global Opportunity ETF (GKAT)

Rating:66Neutral

Price Target:

$44.00

The Scharf Global Opportunity ETF (GKAT) has an overall rating that reflects a mix of strengths and challenges across its holdings. Microsoft stands out as a key contributor, driven by its strong financial performance and growth in cloud and AI services, which position it well for future growth. However, Brookfield Corporation's high leverage and declining revenue growth may have held back the ETF’s rating. A potential risk factor is the ETF's exposure to companies with high valuation concerns, which could limit upside potential.

Positive Factors

Strong Top Holdings

Several key positions, such as Franco-Nevada and McKesson, have delivered strong year-to-date performance, supporting the ETF's overall returns.

Sector Diversification

The ETF is spread across multiple sectors, including Health Care, Financials, and Technology, reducing reliance on any single industry.

Steady Asset Growth

The fund has a healthy level of assets under management, indicating investor confidence and stability.

Negative Factors

High Geographic Concentration

With over 87% of its exposure in U.S. companies, the ETF lacks significant diversification across global markets.

Underperforming Holdings

Some top holdings, such as Fiserv and Haleon, have lagged in performance, potentially dragging on overall returns.

Moderate Expense Ratio

The ETF's expense ratio is higher than some low-cost alternatives, which could eat into long-term returns.

GKAT vs. SPDR S&P 500 ETF (SPY)

AUM129.21M

RegionGlobal

Expense Ratio0.59%

Beta0.71

IssuerScharf

Inception DateAug 25, 2025

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume7,495

30 Day Avg. Volume3,537

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

44.55

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering38

GKAT Summary

The Scharf Global Opportunity ETF (GKAT) is an actively managed fund designed to invest in companies worldwide, aiming for long-term growth. It focuses on the total market and includes a mix of sectors like healthcare, financials, and technology. Some well-known companies it holds are Microsoft and McKesson. This ETF might appeal to investors looking for global diversification and a carefully selected portfolio of high-potential stocks. However, since it invests heavily in U.S. companies and specific sectors like healthcare, its performance can be impacted by changes in those areas or broader market trends.

How much will it cost me?The Scharf Global Opportunity ETF (GKAT) has an expense ratio of 0.59%, which means you’ll pay $5.90 per year for every $1,000 invested. This is higher than average because it’s actively managed, requiring more research and analysis compared to passively managed funds that track an index.

What would affect this ETF?The Scharf Global Opportunity ETF (GKAT) could benefit from growth in the healthcare and technology sectors, which make up a significant portion of its holdings, as well as global economic recovery driving demand for industrial and financial services. However, rising interest rates or regulatory changes could negatively impact financial and technology stocks, while geopolitical tensions or slowing global growth might affect its broad geographic exposure. The fund's focus on high-conviction investments also introduces risks if key holdings underperform.

GKAT Top 10 Holdings

The Scharf Global Opportunity ETF (GKAT) leans heavily into health care and financials, with names like McKesson and Novartis providing steady growth thanks to strong earnings and strategic initiatives. AstraZeneca is also rising, buoyed by bullish sentiment and robust performance. On the flip side, Brookfield Corporation and Fiserv are dragging the fund, with mixed financial results and valuation concerns. Technology plays a smaller role, with Microsoft offering stable growth but facing premium pricing challenges. Overall, GKAT’s global focus and sector concentration in health care and financials drive its performance narrative.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
BN	Brookfield Corporation	6.67%	$8.61M	$113.31B	29.51%	61 Neutral
MCK	McKesson	4.70%	$6.07M	$102.68B	64.91%	74 Outperform
FNV	Franco-Nevada	4.42%	$5.71M	$36.44B	42.39%	74 Outperform
ZTS	Zoetis	4.10%	$5.30M	$63.86B	-19.40%	76 Outperform
UNP	Union Pacific	3.95%	$5.10M	$129.80B	-5.70%	66 Neutral
NVS	Novartis	3.83%	$4.95M	$234.73B	13.11%	73 Outperform
HEINY	Heineken	3.68%	$4.75M	$43.88B	-5.33%	78 Outperform
MSFT	Microsoft	3.67%	$4.74M	$3.91T	29.38%	82 Outperform
HLN	Haleon PLC Sponsored ADR	3.07%	$3.97M	$41.10B	-5.26%	69 Neutral
CB	Chubb	3.06%	$3.95M	$109.43B	-1.55%	78 Outperform

GKAT Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

100DMA

200DMA

Market Momentum

MACD

0.04

Positive

RSI

36.78

Neutral

STOCH

14.61

Positive

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GKAT, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 40.16, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.04 indicates Positive momentum. The RSI at 36.78 is Neutral, neither overbought nor oversold. The STOCH value of 14.61 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GKAT.

GKAT Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
GKAT	―	―	$129.21M	0.59%	66 Neutral
KAT	―	―	$758.58M	0.75%	69 Neutral
RGEF	―	―	$755.58M	0.55%	71 Outperform
DWLD	―	―	$481.75M	0.63%	62 Neutral
FMAG	―	―	$281.87M	0.59%	75 Outperform
NANC	―	―	$265.74M	0.74%	75 Outperform

Performance Comparison

GKAT

Scharf Global Opportunity ETF

39.22

0.59

1.53%

KAT

Scharf ETF

―

RGEF

Rockefeller Global Equity ETF

―

DWLD

Davis Select Worldwide Etf

―

FMAG

Fidelity Magellan ETF

―

NANC

Unusual Whales Subversive Democratic Trading ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents